| Date Filed | Type | Description |
| 10/12/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/27/2023 |
SC 13D
| Redmile Group, LLC reports a 6.6% stake in NEOLEUKIN THERAPEUTICS, INC. |
| 06/28/2023 |
SC 13D/A
| Redmile Group, LLC reports a 9.9% stake in IGM Biosciences, Inc. |
| 06/15/2023 |
SC 13D/A
| Redmile Group, LLC reports a 44.7% stake in Augmedix, Inc. |
| 05/04/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/21/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/19/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/08/2023 |
SC 13G
| Redmile Group, LLC reports a 6.8% stake in AYALA PHARMACEUTICALS, Inc. |
| 02/08/2023 |
SC 13G/A
| Redmile Group, LLC reports a 0% stake in OLD AYALA, Inc. |
| 02/03/2023 |
SC 13G/A
| Redmile Group, LLC reports a 9.7% stake in Stoke therapeutics, Inc. |
| 11/18/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 11/18/2022 |
SC 13G/A
| Redmile Group, LLC reports a 9.9% stake in Replimune Group, Inc. |
| 10/17/2022 |
SC 13G
| Redmile Group, LLC reports a 10.1% stake in Zymeworks Inc. |
| 10/05/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/02/2022 |
SC 13D/A
| Redmile Group, LLC reports a 40.8% stake in Augmedix, Inc. |
| 08/08/2022 |
SC 13G
| Redmile Group, LLC reports a 9.9% stake in Zymeworks Inc. |
| 07/18/2022 |
SC 13G/A
| Redmile Group, LLC reports a 9.9% stake in ANNEXON, Inc. |
| 07/06/2022 |
SC 13D/A
| Redmile Group, LLC reports a 50.7% stake in MedAvail Holdings, Inc. |
| 06/27/2022 |
SC 13G/A
| Redmile Group, LLC reports a 9.9% stake in Scholar Rock Holding Corporation |
| 06/15/2022 |
SC 13D/A
| Redmile Group, LLC reports a 17.1% stake in Science 37 Holdings, Inc. |
| 06/03/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/09/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/06/2022 |
SC 13D/A
| Redmile Group, LLC reports a 41.8% stake in MedAvail Holdings, Inc. |
| 04/05/2022 |
SC 13D/A
| Redmile Group, LLC reports a 12.9% stake in IGM Biosciences, Inc. |
| 02/14/2022 |
SC 13G/A
| Redmile Group, LLC reports a 4.6% stake in Akero Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| Redmile Group, LLC reports a 10% stake in Amicus Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| Redmile Group, LLC reports a 9.9% stake in AYALA PHARMACEUTICALS, Inc. |
| 02/14/2022 |
SC 13G/A
| Redmile Group, LLC reports a 8.5% stake in IMMUNOGEN, INC. |
| 02/14/2022 |
SC 13G/A
| Redmile Group, LLC reports a 7.3% stake in Krystal Biotech, Inc. |
| 02/14/2022 |
SC 13G/A
| Redmile Group, LLC reports a 10.9% stake in lAVA THERAPEUTICS N.V. |
| 02/14/2022 |
SC 13G/A
| Redmile Group, LLC reports a 9.9% stake in NEOLEUKIN THERAPEUTICS, INC. |
| 02/14/2022 |
SC 13G/A
| Redmile Group, LLC reports a 9.9% stake in Replimune Group, Inc. |
| 02/14/2022 |
SC 13G/A
| Redmile Group, LLC reports a 9.9% stake in Scholar Rock Holding Corporation |
|